Integrated biomarkers and cardiac phenotypes associated with atrial fibrillation: evidence from real-world hospital data
Frontiers in Cardiovascular Medicine · 15.05.2026 · 13
DOI: 10.3389/fcvm.2026.1821154 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 15.05.2026. Verfasst von Xuli Chen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Electrocardiology, The Second Affiliated Hospital of Wannan Medical University, Wuhu, China. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
This study aimed to investigate the association between the B-type natriuretic peptide (BNP)/ left ventricular ejection fraction (LVEF) and atrial fibrillation (AF) and to evaluate its discriminative performance in a real-world hospitalized population.
Methods
We conducted a hospital-based observational study that included 270 consecutive patients hospitalized at the Second Affiliated Hospital of Wannan Medical University between August 2023 and December 2025. BNP/LVEF was calculated by dividing plasma BNP levels by LVEF measured by transthoracic echocardiography. AF was diagnosed based on cardiac rhythm recordings during hospitalization or physician diagnosis. We used a multivariate logistic regression model to analyze the association between BNP/LVEF and atrial fibrillation. Restricted cubic spline analysis was used to explore potential non-linear relationships. Receiver operating characteristic (ROC) curves were used to assess discriminatory performance, and pre-specified subgroup analyses were performed to evaluate effect modification.
Results
Among 270 patients, 123 (45.6%) had atrial fibrillation. In all adjusted models, higher BNP/LVEF values were independently associated with an increased risk of atrial fibrillation in fully adjusted model (OR, 1.02; 95% CI, 1.01–1.04). Restricted cubic spline analysis revealed a significant non-linear association (P-nonlinear 0.001), with a sharp increase in the risk of atrial fibrillation at lower BNP/LVEF levels, followed by a plateau. BNP/LVEF demonstrated good discriminatory ability for atrial fibrillation (AUC = 0.84) in the full unadjusted model. Subgroup analysis showed significant heterogeneity across sex, smoking, alcohol consumption, and coronary heart disease status.
Conclusion
BNP/LVEF is independently and nonlinearly associated with atrial fibrillation and demonstrates good discriminative performance. This integrative marker may provide clinically useful information for AF risk stratification in hospitalized patients.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Electrocardiology, The Second Affiliated Hospital of Wannan Medical University, Wuhu, China.
- School of Pharmacy, Wannan Medical University, Wuhu, China.
- Department of Medical Service, The Second Affiliated Hospital of Wannan Medical University, Wuhu, China.
- Eastern Theater Command Centers for Disease Control and Prevention, Nanjing, China.
Zitieren
APA
Chen, X., Ning, Y., Wang, Y., Hu, Y., Liu, Y., & Xiao, W. (2026). Integrated biomarkers and cardiac phenotypes associated with atrial fibrillation: evidence from real-world hospital data. Frontiers in Cardiovascular Medicine, 13. https://doi.org/10.3389/fcvm.2026.1821154
Vancouver
Chen X, Ning Y, Wang Y, Hu Y, Liu Y, Xiao W. Integrated biomarkers and cardiac phenotypes associated with atrial fibrillation: evidence from real-world hospital data. Frontiers in Cardiovascular Medicine. 2026;13. doi:10.3389/fcvm.2026.1821154
BibTeX
@article{Chen2026,
author = {Chen, Xuli and Ning, Yanxi and Wang, Yuxiang and Hu, Yuelin and Liu, Yanchao and Xiao, Wenwen},
title = {Integrated biomarkers and cardiac phenotypes associated with atrial fibrillation: evidence from real-world hospital data},
journal = {Frontiers in Cardiovascular Medicine},
year = {2026},
volume = {13},
doi = {10.3389/fcvm.2026.1821154}
}
EUVIMED